Dr. Martens’ recent IPO valued UK bootmakers at £ 3.7bn, as stocks have been popular since the end of January, despite a slight downturn in the UK stock market as a whole. The value of the company has already risen to £ 4.9 billion.
Permira acquired the business in 2014 for “only” £ 300m and sold a portion of its stake in the IPO.Currently, the largest new shareholders include GIC private (Singapore’s Sovereign Wealth Fund) holds a little over 4% stake in the company and is worth £ 206m as of Friday’s closing price.
The largest stake in IPO acquisitions is held by US-based money manager BlackRock. BlackRock currently holds up to 6.8% of the company’s shares and holds shares through various funds.
The Times quoted financial data firm Refinitiv as US-based Fidelity Management & Research and UK-based Janus Henderson and Jupiter holding 3.25%, 2.7% and 2.03%, respectively.
It may not seem important who invests in a listed company, but attracting the attention of such a heavyweight name is not just the company itself, but manufacturing some of its products in the UK. It is a vote of trust after Brexit in the company that does. Export globally.
It also helps the company justify the value it has attracted on its floats. Some analysts were surprised that the stock was worth £ 3.7 billion at the time.
Due to current valuations, some components of the good FTSE 100 Index ( Morrisons Supermarket and retail real estate giants Landsec and British Land) also mean that the company may qualify for the FTSE 100 when the next review of its members is scheduled. It will make the stock even more demanding as many funds tracking the index will be forced to buy them.
Copyright © 2021FashionNetwork.com All rights reserved.
When the value reaches £ 4.9 billion, can the pink Dr. Martens participate in the FTSE 100?
Source link When the value reaches £ 4.9 billion, can the pink Dr. Martens participate in the FTSE 100?